Ximenis et al., 2021 - Google Patents
Introducing a squaramide-based self-immolative spacer for controlled drug releaseXimenis et al., 2021
View PDF- Document ID
- 880575701700968718
- Author
- Ximenis M
- Sampedro A
- Martínez-Crespo L
- Ramis G
- Orvay F
- Costa A
- Rotger C
- Publication year
- Publication venue
- Chemical Communications
External Links
Snippet
Herein we report the design, synthesis and assessment of the first example of a squaramide- based self-immolative system triggered by an enzymatic reduction. We have proved that the release of the alkylating agent N′, N′-(bis (2-chloroethyl) benzene)-1, 4-diamine (ANM) …
- 239000000599 controlled substance 0 title description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulfur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ximenis et al. | Introducing a squaramide-based self-immolative spacer for controlled drug release | |
| JP7385356B2 (en) | Divalent bromodomain inhibitors and their uses | |
| EP3273966B1 (en) | Inhibitors of cyclin-dependent kinases | |
| CA2737219C (en) | Halofuginone analogs for inhibition of trna synthetases and uses thereof | |
| KR20160115953A (en) | Diaminopyrimidine benzenesulfone derivatives and uses thereof | |
| RU2750164C2 (en) | Cyanothienotriazolodiazepines and methods for their use | |
| CN113557017B (en) | Inhibitors of cyclin-dependent kinase 7 and uses thereof | |
| CN110225914A (en) | Bicyclic urea kinase inhibitor and application thereof | |
| US20180273573A1 (en) | Inhibitors of menaquinone biosynthesis | |
| JPH09500125A (en) | Prodrugs of protein tyrosine kinase inhibitors | |
| Weise et al. | Intensified biocatalytic production of enantiomerically pure halophenylalanines from acrylic acids using ammonium carbamate as the ammonia source | |
| HUE026507T2 (en) | Enzymatic method for producing cortexolone-17-propionate IV hydrate crystal form | |
| JP2017526741A (en) | Diazepan derivatives and uses thereof | |
| US20190038656A1 (en) | Anthranilyl-adenosinemonosulfamate analogs and uses thereof | |
| EP2004156A2 (en) | Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications | |
| US20250213698A1 (en) | Bicyclic heterocycles and their ligands for targeted delivery of therapeutic agents | |
| CN118076619A (en) | 2 '-Alkyl or 3' -alkyl modified ribose derivatives for in vivo delivery of oligonucleotides | |
| Kopple et al. | Reactivity of Cyclic Peptides. II. cyclo-L-Tyrosyl-L-histidyl and cyclo-L-Tyrosyltriglycyl-L-histidylglycyl | |
| US20130005696A1 (en) | Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof | |
| US9056887B2 (en) | Minor groove binder phosphoramidites and methods of use | |
| Yang et al. | Cationic nucleolipids as efficient siRNA carriers | |
| Cibulka et al. | Catalytic effect of alloxazinium and isoalloxazinium salts on oxidation of sulfides with hydrogen peroxide in micellar media | |
| Cogan et al. | Doxsaliform: A novel N-Mannich base prodrug of a doxorubicin formaldehyde conjugate | |
| JP2008530083A (en) | Cationic lipids for nucleic acid transfection | |
| Costa et al. | Hybrids of macrolides and nucleobases or nucleosides |